San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

AMN Healthcare Investing in Telepharmacy Company

San Diego staffing firm AMN Healthcare Services Inc. will invest $5 million in a series of staged payments to San Francisco telepharmacy company PipelineRx.

Tease photo

BioMed Declares First Quarter Stock Dividend

San Diego-based BioMed Realty Trust Inc. (NYSE: BMR) has declared a first-quarter 2014 dividend of 25 cents per share of common stock, equivalent to $1 per share on an annualized basis.

Tease photo

Mallinckrodt Completes Acquisition of Cadence Pharmaceuticals

Irish specialty drugmaker Mallinckrodt PLC has completed the $1.4 billion purchase of San Diego-based Cadence Pharmaceuticals Inc. The deal was announced initially in February.

New Private Equity-Backed Company Ready to Acquire Life Sciences Firms

Former Gen-Probe executives Carl Hull and Eric Tardif have been tasked by a Chicago-based private equity firm to launch a life sciences company in San Diego aimed at acquiring other companies and with a few hundred million dollars at the ready.

Tease photo

U.S. Reps from San Diego Urge Increase in NIH Funding

U.S. Reps. Susan Davis and Scott Peters, both Democrats from San Diego, gathered with a group of the region’s medical research stakeholders to solicit Congress to increase funding for the National Institutes of Health, which funds much of the medical research taking place in this area.

Tease photo

New Kaiser Medical Office Building to Open

Kaiser Permanente will open a new medical office building in Oceanside on March 17.

AnaptysBio Inc. Partnership Deal Could Be Worth $125M

AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront

AnaptysBio Inc. Deal Could Be Worth $125 Million

AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront.

Today's Bedtime Story

Happy World Sleep Day.

Zogenix’s Powerful Painkiller Faces Attacks From Two Fronts

Things aren’t looking great for Zogenix Inc. nor its flagship drug, the powerful narcotic painkiller Zohydro. The company’s stock recently plummeted on news that a competitor just might have built a better mousetrap — drug — and could soon emerge on the market.

Tease photo

Experience With Illness Is Catalyst for Creating New Business

BIOTECH: Proactive Patient Got to Work on New Mobility Device

Extreme athlete Kim Goodsell has a bevy of health conditions that could severely limit her ability to walk. But with research, ingenuity and sheer pluck she has taken charge of her own health — and launched a new company as a result.

Tease photo

Veteran Exec Smooths Life Tech’s Transition

BIOTECH: Stevenson Is President of New Division

Shepherding thousands of employees through a high-profile merger is highly daunting, but Mark Stevenson considers himself equal to the task. The veteran biotech executive has, after all, done it before.

Tease photo

DJO Global Appoints New CFO

Vista-based medical device maker DJO Global Inc. has appointed Susan Crawford as the company’s new chief financial officer.

Tease photo

Lumena Pharmaceuticals Closes $45M Funding Round

Lumena Pharmaceuticals Inc. has closed a $45 million Series B round, and will use the funding to develop drugs for two diseases of the liver.

Sharp HealthCare Names New Chief Information Officer

Sharp HealthCare has named Ken Lawonn as its new chief information officer. He is replacing Bill Spooner, who retired March 3 after working 35 years for Sharp.